BC
PRAH

Brookfield Corp’s PRA Health Sciences, Inc. PRAH Stock Holding History

Brookfield Corp’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-14,949
Closed -$1.52M – 547
2020
Q3 		$1.52M Buy
+14,949
New +$1.52M 0.01% 272

Other funds holding PRAH

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
PG
Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Brookfield Corp's PRAH Position: Q4 2020 in Review

Brookfield Corp sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2020, closing a stake of 14,949 shares — an estimated $1.52M sold.

Brookfield Corp first reported a position in PRAH in Q3 2020 and held it in 1 quarter. The position peaked at $1.52M in Q3 2020. 289 funds tracked by Wall St. Rank hold PRAH as of Q4 2020.

  • Brookfield Corp reported no remaining PRA Health Sciences, Inc. position as of Q4 2020 after selling out during the quarter.
  • Brookfield Corp sold 14,949 PRA Health Sciences, Inc. shares in Q4 2020, an estimated $1.52M.
  • Brookfield Corp first reported a position in PRA Health Sciences, Inc. in Q3 2020 and held it in 1 quarter.
  • Brookfield Corp's PRA Health Sciences, Inc. position peaked at $1.52M in Q3 2020.
  • 289 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2020.

Based on Brookfield Corp's 13F filing for Q4 2020, filed 16 Feb 2021.